UnitedHealth Group (UNH), a health care and well-being company, reported first-quarter 2026 results, reflecting 2% in revenue growth. In addition, the firm raised the full-year 2026 adjusted earnings guidance.
Following the news, UNH is currently surging 9.42% to $353.96.
Net earnings attributable to UnitedHealth Group common shareholders slipped to $6.28 billion from $6.29 billion in the prior year.
Meanwhile, adjusted earnings per share increased to $7.23 from $7.20 a year ago.
Net earnings increased to $6.48 billion or $6.90 per share from $6.47 billion or $6.85 per share in the prior year.
Revenue increased to $111.72 billion compared to $109.58 billion in the year ago.
Looking ahead, the company now expects full-year 2026 adjusted net earnings to exceed $18.25 per share, up from earlier expectations of more than $17.75 per share.
UnitedHealth Group operates through four segments: Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare.
"We are continuing to help simplify and modernise health care for the people and care providers we serve, bringing greater value, affordability, transparency and connectivity," said Stephen Hemsley, chief executive officer of UnitedHealth Group.
UNH has traded between $234.60 and $438.85 over the last year. The stock closed Monday's trading at $323.48.
For More Such Biotech Stock News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.